0001782226-23-000001.txt : 20231018 0001782226-23-000001.hdr.sgml : 20231018 20231018144037 ACCESSION NUMBER: 0001782226-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231018 DATE AS OF CHANGE: 20231018 EFFECTIVENESS DATE: 20231018 FILER: COMPANY DATA: COMPANY CONFORMED NAME: i2O Therapeutics, Inc. CENTRAL INDEX KEY: 0001782226 IRS NUMBER: 841743853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495121 FILM NUMBER: 231332000 BUSINESS ADDRESS: STREET 1: 13250 VIA ARRIBA DRIVE CITY: SARATOGA STATE: CA ZIP: 95070 BUSINESS PHONE: 408-476-1904 MAIL ADDRESS: STREET 1: 13250 VIA ARRIBA DRIVE CITY: SARATOGA STATE: CA ZIP: 95070 D 1 primary_doc.xml X0708 D LIVE 0001782226 i2O Therapeutics, Inc. 610 Main Street Cambridge MA MASSACHUSETTS 02139 408-476-1904 DELAWARE None None Corporation true 2019 Kurt Graves 610 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Chief Executive Officer Christopher Gagliardi 610 Main Street Cambridge MA MASSACHUSETTS 02139 Director Anthony Aiudi 610 Main Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2023-09-18 false true true true false 0 3987042 3500000 487042 false 7 0 0 0 false i2O Therapeutics, Inc. /s/ Kurt Graves Kurt Graves Chief Executive Officer 2023-10-18